Carl Zeiss Meditec, Inc. Sustainability Profile
Carl Zeiss Meditec, Inc., a prominent player in the medical technology sector, is headquartered in the United States and operates extensively across Europe, Asia, and other global markets. Founded in 2002, the company has rapidly established itself as a leader in ophthalmic devices and surgical instruments, focusing on innovative solutions for vision care and minimally invasive surgery. Renowned for its cutting-edge products, Carl Zeiss Meditec offers advanced imaging systems, surgical microscopes, and diagnostic equipment that enhance precision and patient outcomes. The company’s commitment to research and development has led to significant milestones, including the introduction of groundbreaking technologies in eye care. With a strong market position, Carl Zeiss Meditec continues to set industry standards, making it a trusted name among healthcare professionals worldwide.
DitchCarbon Score
How does Carl Zeiss Meditec, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Carl Zeiss Meditec, Inc.'s score of 39 is higher than 61% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Carl Zeiss Meditec, Inc., headquartered in the US, currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of Carl Zeiss Meditec AG, which may influence its climate commitments and performance metrics. As of now, there are no documented reduction targets or initiatives directly attributed to Carl Zeiss Meditec, Inc. However, emissions data and performance metrics may be inherited from its parent company, Carl Zeiss Meditec AG, which operates at a cascade level of 1. This means that any climate commitments or emissions reductions from the parent company could potentially impact the subsidiary's strategies and goals. In the broader context, the medical technology industry is increasingly focusing on sustainability and reducing carbon footprints. Companies are encouraged to adopt science-based targets and engage in initiatives such as the Carbon Disclosure Project (CDP) to enhance transparency and accountability regarding their environmental impact. While specific figures and commitments are not available for Carl Zeiss Meditec, Inc., the company's affiliation with Carl Zeiss Meditec AG suggests a potential alignment with industry standards and practices aimed at addressing climate change.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Scope 1 | 31,686,000 | 00,000,000 | 0,000,000 | - | 00,000,000 | 00,000,000 |
| Scope 2 | 177,720,000 | 00,000,000 | 000,000,000 | - | 0,000,000 | 0,000,000 |
| Scope 3 | - | 0,000,000,000 | - | 000,000 | - | - |
How Carbon Intensive is Carl Zeiss Meditec, Inc.'s Industry?
How Carbon Intensive is Carl Zeiss Meditec, Inc.'s Location?
Carl Zeiss Meditec, Inc.'s Scope 3 Categories Breakdown
Carl Zeiss Meditec, Inc.'s Scope 3 emissions, which decreased by 100% last year and decreased by approximately 100% since 2020, demonstrating supply chain emissions tracking. Nearly all of their carbon footprint comes from suppliers and value chain emissions, representing nearly all emissions under the GHG Protocol, with "Capital Goods" representing nearly all of their reported Scope 3 footprint.
Top Scope 3 Categories
Carl Zeiss Meditec, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Carl Zeiss Meditec, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
